Empiric anti-thymocyte globulin (ATG) dosing in ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (allo-HCT) may result in ATG overexposure that negatively affects outcomes Meeting Abstract

  

Authors:	Scordo, M.; Bhatt, V.; Smith, M.; Thoren, K.; Hilden, P.; Cho, C.; Shah, G. L.; Maloy, M.; Papadopoulos, E. B.; Jakubowski, A. A.; O'Reilly, R. J.; Castro-Malaspina, H.; Tamari, R.; Shaffer, B. C.; Perales, M. A.; Giralt, S. A.
Abstract Title:	Empiric anti-thymocyte globulin (ATG) dosing in ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (allo-HCT) may result in ATG overexposure that negatively affects outcomes
Meeting Title:	2018 BMT Tandem Meetings
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	24
Issue:	3 Suppl. 1
Meeting Dates:	2018 Feb 21-25
Meeting Location:	Salt Lake City, UT
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2018-03-01
Start Page:	S71
End Page:	S72
Language:	English
ACCESSION:	WOS:000425476000075
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2017.12.653
Notes:	Meeting Abstract: 71 -- Meeting date is incorrect in the original publication's table of contents -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/122608